Literature DB >> 29523595

Interleukin-3 stimulates matrix metalloproteinase 12 production from macrophages promoting thoracic aortic aneurysm/dissection.

Chang Liu1, Congcong Zhang1, Lixin Jia1,2, Boya Chen1, Luxin Liu1, Jie Sun1, Wenmei Zhang1, Bin You1, Yulin Li1, Ping Li3, Jie Du3.   

Abstract

Thoracic aortic aneurysm and dissection (TAAD) is due to degeneration of the aorta and causes a high mortality rate, while molecular mechanisms for the development of TAAD are still not completely understood. In the present study, 3-aminopropionitrile (BAPN) treatment was used to induce TAAD mouse model. Through transcriptome analysis, we found the expression levels of genes associated with interleukin-3 (IL-3) signaling pathway were up-regulated during TAAD development in mouse, which were validated by real-time PCR. IL-3 positive cells were increased in TAAD mouse aortas, especially for smooth muscle cells (SMCs). IL-3 deficiency reduced BAPN-induced TAAD formation. We then examined the matrix metalloproteinases (MMPs) expression during TAAD formation in both wild-type and IL-3 deficient mice, showing that MMP12 were significantly down-regulated in IL-3 deficient aortas. Mechanistically, we found recombinant IL-3 could increase MMP12 production and activity from macrophages in vitro Silencing of IL-3 receptor β, which was mainly expressed in macrophages but not SMCs, diminished the activation of c-Jun N terminal kinase (JNK)/extracellular-regulated protein kinases 1/2 (ERK1/2)/AP-1 signals, and decreased MMP12 expression in IL-3 stimulated macrophages. Moreover, both circulating and aortic inflammation were decreased in IL-3 deficient aortas. Taken together, our results demonstrated that IL-3 stimulated the production of MMP12 from macrophages by a JNK- and ERK1/2-dependent AP-1 pathway, contributing to TAAD formation. Thus, the IL-3/IL-3Rβ/MMP12 signals activation may be an important pathological mechanism for progression of TAAD.
© 2018 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  Interleukin-3; Macrophage; Matrix metallopeptidase 12; Thoracic aortic aneurysm and dissection

Mesh:

Substances:

Year:  2018        PMID: 29523595     DOI: 10.1042/CS20171529

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  6 in total

1.  Are IL1B, IL6 and IL6R Gene Variants Associated with Anterior Cruciate Ligament Rupture Susceptibility?

Authors:  Ewelina Lulińska-Kuklik; Ewelina Maculewicz; Waldemar Moska; Krzysztof Ficek; Mariusz Kaczmarczyk; Monika Michałowska-Sawczyn; Kinga Humińska-Lisowska; Maciej Buryta; Jakub Chycki; Pawel Cięszczyk; Piotr Żmijewski; Agata Rzeszutko; Marek Sawczuk; Petr Stastny; Miroslav Petr; Agnieszka Maciejewska-Skrendo
Journal:  J Sports Sci Med       Date:  2019-02-11       Impact factor: 2.988

Review 2.  Matrix Metalloproteinase in Abdominal Aortic Aneurysm and Aortic Dissection.

Authors:  Eithne M Maguire; Stuart W A Pearce; Rui Xiao; Aung Y Oo; Qingzhong Xiao
Journal:  Pharmaceuticals (Basel)       Date:  2019-08-06

3.  Serum amyloid a protein as a potential biomarker in predicting acute onset and association with in-hospital death in acute aortic dissection.

Authors:  Yuchen He; Changcheng Ma; Jia Xing; Shiyue Wang; Chao Ji; Yanshuo Han; Jian Zhang
Journal:  BMC Cardiovasc Disord       Date:  2019-12-03       Impact factor: 2.298

Review 4.  β-Aminopropionitrile-induced aortic aneurysm and dissection in mice.

Authors:  Hisashi Sawada; Zachary A Beckner; Sohei Ito; Alan Daugherty; Hong S Lu
Journal:  JVS Vasc Sci       Date:  2022-01-03

Review 5.  The genetics and biomechanics of thoracic aortic diseases.

Authors:  Amer Harky; Ka Siu Fan; Ka Hay Fan
Journal:  Vasc Biol       Date:  2019-10-15

Review 6.  The Role of Inflammation and Myeloperoxidase-Related Oxidative Stress in the Pathogenesis of Genetically Triggered Thoracic Aortic Aneurysms.

Authors:  Cassandra Malecki; Brett D Hambly; Richmond W Jeremy; Elizabeth N Robertson
Journal:  Int J Mol Sci       Date:  2020-10-16       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.